Archived App (Last seen on 30 Jul 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This is a research companion app to the Tetrathiomolybdate (TM) Copper Trial for individuals with breast cancer. The app will remind you about your TM dosing schedule and enable you to log doses that you are taking daily. App usage requires study registration with the TM Copper Trial team.
Show more
What's New in TM Dosing Logger
1.3
November 4, 2025
Bug fixes, display improvements, improvements to adding new cycles and user authentication
